Azstarys (serdexmethylphenidate/dexmethylphenidate oral) / Zevra Therap, Ark Biosci, Corium, Commave Therap  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Azstarys (serdexmethylphenidate/dexmethylphenidate oral) / Corium
NCT03292952: KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

Checkmark Efficacy and safety data from KP415.E01 study
Jul 2018 - Jul 2018: Efficacy and safety data from KP415.E01 study
Checkmark Efficacy and safety data from KP415.E01 study [screenshot]
Jul 2018 - Jul 2018: Efficacy and safety data from KP415.E01 study [screenshot]
Checkmark KP415 Classroom study in children
More
Completed
3
155
US
KP415 oral capsule, Placebo oral capsule
KemPharm, Inc.
ADHD
05/18
05/18
NCT03460652: KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD

Checkmark IV HAP data [screenshot]
May 2018 - May 2018: IV HAP data [screenshot]
Completed
3
282
US
KP415 oral capsule, Azstarys, SDX/d-MPH
KemPharm, Inc.
ADHD
06/19
07/19
NCT06359899: A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD

Not yet recruiting
3
50
RoW
AK0901 capsule, AZSTARYS (SDX/d-MPH capsules), Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
ADHD
09/24
10/24

Download Options